BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32276394)

  • 1. Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.
    Shih YC; Wu CC; Wang SC; Liou JY; Huang PH; Tarng DC
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32276394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120.
    Six I; Gross P; Rémond MC; Chillon JM; Poirot S; Drueke TB; Massy ZA
    Atherosclerosis; 2015 Nov; 243(1):248-56. PubMed ID: 26408929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration of smooth muscle cells from the arterial anastomosis of arteriovenous fistulas requires Notch activation to form neointima.
    Liang M; Wang Y; Liang A; Mitch WE; Roy-Chaudhury P; Han G; Cheng J
    Kidney Int; 2015 Sep; 88(3):490-502. PubMed ID: 25786100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula.
    Liang A; Wang Y; Han G; Truong L; Cheng J
    Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1413-20. PubMed ID: 23576636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CharXgen-Activated Bamboo Charcoal Encapsulated in Sodium Alginate Microsphere as the Absorbent of Uremic Toxins to Retard Kidney Function Deterioration.
    Lin CJ; Sun CY; Wu CJ; Wu CC; Wu V; Lin FH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.
    Shih YC; Chen PY; Ko TM; Huang PH; Ma H; Tarng DC
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation.
    Yang B; Janardhanan R; Vohra P; Greene EL; Bhattacharya S; Withers S; Roy B; Nieves Torres EC; Mandrekar J; Leof EB; Mukhopadhyay D; Misra S
    Kidney Int; 2014 Feb; 85(2):289-306. PubMed ID: 23924957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Repeat Administration of Adventitial Delivery of Lentivirus-shRNA-Vegf-A in Arteriovenous Fistula to Prevent Venous Stenosis Formation.
    Janardhanan R; Yang B; Kilari S; Leof EB; Mukhopadhyay D; Misra S
    J Vasc Interv Radiol; 2016 Apr; 27(4):576-83. PubMed ID: 26948326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.
    Yamamoto S; Zuo Y; Ma J; Yancey PG; Hunley TE; Motojima M; Fogo AB; Linton MF; Fazio S; Ichikawa I; Kon V
    Nephrol Dial Transplant; 2011 Aug; 26(8):2491-7. PubMed ID: 21245127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas.
    Kokubo T; Ishikawa N; Uchida H; Chasnoff SE; Xie X; Mathew S; Hruska KA; Choi ET
    J Am Soc Nephrol; 2009 Jun; 20(6):1236-45. PubMed ID: 19423694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.
    Janardhanan R; Yang B; Vohra P; Roy B; Withers S; Bhattacharya S; Mandrekar J; Kong H; Leof EB; Mukhopadhyay D; Misra S
    Kidney Int; 2013 Aug; 84(2):338-52. PubMed ID: 23636169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AST-120, an Adsorbent of Uremic Toxins, Improves the Pathophysiology of Heart Failure in Conscious Dogs.
    Asanuma H; Chung H; Ito S; Min KD; Ihara M; Takahama H; Funayama M; Imazu M; Fukuda H; Ogai A; Asano Y; Minamino T; Takashima S; Morita T; Sugimachi M; Asakura M; Kitakaze M
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):277-286. PubMed ID: 30903544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
    Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
    Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metabolomic approach to clarifying the effect of AST-120 on 5/6 nephrectomized rats by capillary electrophoresis with mass spectrometry (CE-MS).
    Akiyama Y; Takeuchi Y; Kikuchi K; Mishima E; Yamamoto Y; Suzuki C; Toyohara T; Suzuki T; Hozawa A; Ito S; Soga T; Abe T
    Toxins (Basel); 2012 Nov; 4(11):1309-22. PubMed ID: 23202318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats.
    Niwa T; Yazawa T; Ise M; Sugano M; Kodama T; Uehara Y; Maeda K
    Nephron; 1991; 57(1):84-8. PubMed ID: 1904558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.